A series of Dutch newsletters in print and online on the subject of deep vein thrombosis and pulmonary embolism in oncology patients. In conjunction, there is also a website www.thrombosismatters.nl, which will be launched in the near future.
Clients
Bayer Nederland BV en Bayer Netherlands BV
Indication
Thrombosis
Target audience
Cardiologists, hematologists and vascular specialists in the Netherlands
Goal
Providing education regarding the usage of rivaroxaban in the treatment of cancer-related thrombosis and pulmonary embolism, based on the most recent data from clinical trials, congresses and international publications.
Result
This project has only just started in 2020, the number of subsribers is rising steadily.
